Prototype of clinical trials in an untrustworthy environment using blockchain

Upon completion, cleaned data and analysis scripts are sent to the trial sponsor through the portal and these transactions are subsequently recorded onto the blockchain. When the trial sponsor wishes to apply for approval of the drug, the sponsor would send all of their finalized data and in house statistical analysis results to the regulator through the portal and these, like all other elements, would be subsequently added to the chain. We downloaded the completed clinical trials data, including all necessary components, such as raw data, case report form (CRF) components, and protocols from the open clinical trials data repository ImmPort14 (see Data Availability).

Source: www.nature.com